Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Improving these processes involves adjusting various parameters, including cell line selection, media ingredients, and bioreactor environments. A key goal is to maximize antibody production while reducing production cost